The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
Open accessAbstract
Several emerging plasma biomarkers may ultimately prove useful in risk stratification and prognosis of cardiovascular disease. The clinical utility of these biomarkers will depend on their ability to provide a reflection of the underlying atherosclerotic burden or activity; the ability to provide reliable, accurate, and cost-effective information; and the ability to predict future events. High-sensitivity C-reactive protein (hs-CRP) fulfills many, if not all, of these criteria, and blood levels of hs-CRP are now commonly used in clinical practice to improve vascular risk prediction in primary and secondary prevention across all levels of low-density lipoprotein-cholesterol (LDL-C), all levels of the Framingham Risk Score, and all levels of metabolic syndrome. High-sensitivity C-reactive protein may also have clinical relevance as an adjunct to LDL-C for both the targeting and monitoring of statin therapy. Accumulating evidence suggests that several other selected emerging biomarkers may also potentially prove useful in the diagnosis and prognosis of cardiovascular disease. Specifically, data are accumulating on the potential clinical utility of lipoprotein-associated lipoprotein-associated phospholipase A2, myeloperoxidase, oxidized LDL, lipoprotein (a), isoprostanes, and small, dense LDL. This review focuses on hs-CRP and these emerging plasma biomarkers, and their potential diagnostic and prognostic utility in cardiovascular disease. Plasma biomarkers that reflect the clinical potential of atherothrombotic disease may allow more precise risk stratification and prognostication in high-risk populations, and perhaps earlier diagnosis and intervention in patients at risk for or with occult cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enzymatic Determination of Total Serum Cholesterol
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,125
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citationDanesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Self-citationThe Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Self-citationRidker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Self-citationAlbert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,641
Self-citationRidker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Self-citationSattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S. D., Gallimore, J. R., & Group, M. B. P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,500
Prevalence of Conventional Risk Factors in Patients With Coronary Heart Disease
Khot, U. N. (2003) · JAMA · doi:10.1001/jama.290.7.898 · Cited by 1,494
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., & Braunwald, E. (1999) · Circulation · doi:10.1161/01.cir.100.3.230 · Cited by 1,478
Self-citationRidker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
Self-citationStatin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,296
Self-citationDaugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Lindahl, B., Toss, H., Siegbahn, A., Venge, P., & Wallentin, L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431602 · Cited by 1,224
Inflammatory Markers and the Risk of Coronary Heart Disease in Men and Women
Pai, J. K., Pischon, T., Ma, J., Manson, J. E., Hankinson, S. E., Joshipura, K., Curhan, G. C., Rifai, N., Cannuscio, C. C., Stampfer, M. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040967 · Cited by 1,174
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M.-L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,070
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Verma, S., Wang, C.-H., Li, S.-H., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R.-K., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,054
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Münzel, T., Simoons, M. L., & Hamm, C. W. (2003) · Circulation · doi:10.1161/01.cir.0000090690.67322.51 · Cited by 1,013
Crisby, M., Nordin-Fredriksson, G., Shah, P. K., Yano, J., Zhu, J., & Nilsson, J. (2001) · Circulation · doi:10.1161/01.cir.103.7.926 · Cited by 1,001
Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Zhang, R. (2001) · JAMA · doi:10.1001/jama.286.17.2136 · Cited by 918
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
Function of C-reactive protein
Du Clos, T. W. (2000) · Annals of Medicine · doi:10.3109/07853890009011772 · Cited by 801
Rost, N. S., Wolf, P. A., Kase, C. S., Kelly-Hayes, M., Silbershatz, H., Massaro, J. M., D'Agostino, R. B., Franzblau, C., & Wilson, P. W. F. (2001) · Stroke · doi:10.1161/hs1101.098151 · Cited by 801
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
Self-citationMorrow, D. A., Rifai, N., Antman, E. M., Weiner, D. L., McCabe, C. H., Cannon, C. P., & Braunwald, E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00136-3 · Cited by 782
Ehara, S., Ueda, M., Naruko, T., Haze, K., Itoh, A., Otsuka, M., Komatsu, R., Matsuo, T., Itabe, H., Takano, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.15.1955 · Cited by 781
Ridker, P. M., Rifai, N., & Clearfield, M. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00460-3 · Cited by 760
Self-citationRidker, P. M., Rifai, N., Cook, N. R., Bradwin, G., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.3.326 · Cited by 744
Self-citationZheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., & Braunwald, E. (2002) · Circulation · doi:10.1161/01.cir.0000015464.18023.0a · Cited by 735
Jialal, I., Stein, D., Balis, D., Grundy, S. M., Adams-Huet, B., & Devaraj, S. (2001) · Circulation · doi:10.1161/01.cir.103.15.1933 · Cited by 730
Sugiyama, S., Okada, Y., Sukhova, G. K., Virmani, R., Heinecke, J. W., & Libby, P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64036-9 · Cited by 699
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 688
Neutrophil Infiltration of Culprit Lesions in Acute Coronary Syndromes
Naruko, T., Ueda, M., Haze, K., van der Wal, A. C., van der Loos, C. M., Itoh, A., Komatsu, R., Ikura, Y., Ogami, M., Shimada, Y., et al. (2002) · Circulation · doi:10.1161/01.cir.0000042674.89762.20 · Cited by 660
Ridker, P. M., Wilson, P. W. F., & Grundy, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000132467.45278.59 · Cited by 645
Self-citationArmstrong, V. W., Cremer, P., Eberle, E., Manke, A., Schulze, F., Wieland, H., Kreuzer, H., & Seidel, D. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90099-7 · Cited by 626
Ballantyne, C. M., Hoogeveen, R. C., Bang, H., Coresh, J., Folsom, A. R., Heiss, G., & Sharrett, A. R. (2004) · Circulation · doi:10.1161/01.cir.0000116763.91992.f1 · Cited by 613
Calabró, P., Willerson, J. T., & Yeh, E. T. H. (2003) · Circulation · doi:10.1161/01.cir.0000096055.62724.c5 · Cited by 566
Self-citationSingle LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
Tamai, O., Matsuoka, H., Itabe, H., Wada, Y., Kohno, K., & Imaizumi, T. (1997) · Circulation · doi:10.1161/01.cir.95.1.76 · Cited by 542
A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction
Ridker, P. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180065035 · Cited by 512
Self-citationSchaefer, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510370051031 · Cited by 487
Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy
Shishehbor, M. H., Aviles, R. J., Brennan, M.-L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, J. F., Penn, M. S., Sprecher, D. L., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1675 · Cited by 464 · cited 1×
“Interestingly, atorvastatin has been shown to educe levels of MPO-derived oxidants, independent of the ipid-lowering effects, suggesting specific antioxidant proprties (76,77).”
BackgroundPodrez, E. A., Febbraio, M., Sheibani, N., Schmitt, D., Silverstein, R. L., Hajjar, D. P., Cohen, P. A., Frazier, W. A., Hoff, H. F., & Hazen, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8574 · Cited by 455
Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454
Morrow, J. D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000152605.64964.c0 · Cited by 453
St-Pierre, A. C., Cantin, B., Dagenais, G. R., Mauriège, P., Bernard, P.-M., Després, J.-P., & Lamarche, B. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154144.73236.f4 · Cited by 422
Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age
Sandkamp, M., Funke, H., Schulte, H., Köhler, E., & Assmann, G. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.1.20 · Cited by 417
Sugiyama, S., Kugiyama, K., Aikawa, M., Nakamura, S., Ogawa, H., & Libby, P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000131784.50633.4f · Cited by 414
Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability
Nishi, K., Itabe, H., Uno, M., Kitazato, K. T., Horiguchi, H., Shinno, K., & Nagahiro, S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000033829.14012.18 · Cited by 409
Toshima, S.-I., Hasegawa, A., Kurabayashi, M., Itabe, H., Takano, T., Sugano, J., Shimamura, K., Kimura, J., Michishita, I., Suzuki, T., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2243 · Cited by 407
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
Shishehbor, M. H., Brennan, M.-L., Aviles, R. J., Fu, X., Penn, M. S., Sprecher, D. L., & Hazen, S. L. (2003) · Circulation · doi:10.1161/01.cir.0000080895.05158.8b · Cited by 405
Cushman, M., Arnold, A. M., Psaty, B. M., Manolio, T. A., Kuller, L. H., Burke, G. L., Polak, J. F., & Tracy, R. P. (2005) · Circulation · doi:10.1161/circulationaha.104.504159 · Cited by 368
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita, J. A., Brennan, M.-L., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, J. F., & Hazen, S. L. (2004) · Circulation · doi:10.1161/01.cir.0000140262.20831.8f · Cited by 365
Tsimikas, S., Bergmark, C., Beyer, R. W., Patel, R., Pattison, J., Miller, E., Juliano, J., & Witztum, J. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02769-9 · Cited by 349
Self-citationHulthe, J., & Fagerberg, B. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000021150.63480.cd · Cited by 345
Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
Praticò, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J. A., Rokach, J., Maclouf, J., Violi, F., & FitzGerald, G. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119735 · Cited by 344
Holvoet, P., Kritchevsky, S. B., Tracy, R. P., Mertens, A., Rubin, S. M., Butler, J., Goodpaster, B., & Harris, T. B. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1068 · Cited by 318
Koenig, W., Khuseyinova, N., Löwel, H., Trischler, G., & Meisinger, C. (2004) · Circulation · doi:10.1161/01.cir.0000143377.53389.c8 · Cited by 311
Effects of Lowering Elevated LDL Cholesterol on the Cardiovascular Risk of Lipoprotein(a)
Maher, V. M. G. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220037029 · Cited by 298
Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly
Ariyo, A. A., Thach, C., & Tracy, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa001066 · Cited by 288
Tsimikas, S., Lau, H. K., Han, K.-R., Shortal, B., Miller, E. R., Segev, A., Curtiss, L. K., Witztum, J. L., & Strauss, B. H. (2004) · Circulation · doi:10.1161/01.cir.0000130844.01174.55 · Cited by 285
Self-citationIncreased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic Mice
Danenberg, H. D., Szalai, A. J., Swaminathan, R. V., Peng, L., Chen, Z., Seifert, P., Fay, W. P., Simon, D. I., & Edelman, E. R. (2003) · Circulation · doi:10.1161/01.cir.0000085568.13915.1e · Cited by 285
Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
Itabe, H., Yamamoto, H., Imanaka, T., Shimamura, K., Uchiyama, H., Kimura, J., Sanaka, T., Hata, Y., & Takano, T. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37634-3 · Cited by 277
PALINSKI, W., & NAPOLI, C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0226rev · Cited by 268
Pennathur, S., Bergt, C., Shao, B., Byun, J., Kassim, S. Y., Singh, P., Green, P. S., McDonald, T. O., Brunzell, J., Chait, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406762200 · Cited by 264
Zambon, A., Hokanson, J. E., Brown, B. G., & Brunzell, J. D. (1999) · Circulation · doi:10.1161/01.cir.99.15.1959 · Cited by 263
Measurement issues related to lipoprotein heterogeneity
Otvos, J. D., Jeyarajah, E. J., & Cromwell, W. C. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02632-2 · Cited by 260
Lipoprotein-Associated Phospholipase A
Krumholz, H. (2001) · Journal watch · doi:10.1056/jc200101050000008 · Cited by 254
Cushing, G. L., Gaubatz, J. W., Nava, M. L., Burdick, B. J., Bocan, T. M., Guyton, J. R., Weilbaecher, D., DeBakey, M. E., Lawrie, G. M., & Morrisett, J. D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.593 · Cited by 252
Häkkinen, T., Luoma, J. S., Hiltunen, M. O., Macphee, C. H., Milliner, K. J., Patel, L., Rice, S. Q., Tew, D. G., Karkola, K., & Ylä-Herttuala, S. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.2909 · Cited by 239
Brilakis, E. S., McConnell, J. P., Lennon, R. J., Elesber, A. A., Meyer, J. G., & Berger, P. B. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi010 · Cited by 230
Tsimikas, S., Witztum, J. L., Miller, E. R., Sasiela, W. J., Szarek, M., Olsson, A. G., & Schwartz, G. G. (2004) · Circulation · doi:10.1161/01.cir.0000141728.23033.b5 · Cited by 225
Self-citationShaw, P. X., Hörkkö, S., Tsimikas, S., Chang, M.-K., Palinski, W., Silverman, G. J., Chen, P. P., & Witztum, J. L. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0801.093587 · Cited by 222
Self-citationBlake, G. J., Dada, N., Fox, J. C., Manson, J. E., & Ridker, P. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01554-6 · Cited by 211
Self-citationHemelaar, J., Lelyveld, V. S., Kessler, B. M., & Ploegh, H. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308762200 · Cited by 210
Nikpoor, B., Turecki, G., Fournier, C., Théroux, P., & Rouleau, G. A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116769 · Cited by 209
Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma
Aikawa, M., Sugiyama, S., Hill, C. C., Voglic, S. J., Rabkin, E., Fukumoto, Y., Schoen, F. J., Witztum, J. L., & Libby, P. (2002) · Circulation · doi:10.1161/01.cir.0000028465.52694.9b · Cited by 204
Steinberg, D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400003-jlr200 · Cited by 202
Quarck, R., De Geest, B., Stengel, D., Mertens, A., Lox, M., Theilmeier, G., Michiels, C., Raes, M., Bult, H., Collen, D., et al. (2001) · Circulation · doi:10.1161/01.cir.103.20.2495 · Cited by 193
Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice
Hirschfield, G. M., Gallimore, J. R., Kahan, M. C., Hutchinson, W. L., Sabin, C. A., Benson, G. M., Dhillon, A. P., Tennent, G. A., & Pepys, M. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503202102 · Cited by 192
Lipoprotein(a): intrigues and insights
Hobbs, H. H., & White, A. L. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00005 · Cited by 179
Novel Risk Markers and Clinical Practice
Manolio, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038136 · Cited by 174
Marathe, G. K., Zimmerman, G. A., & McIntyre, T. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211126200 · Cited by 173
Mallat, Z., Nakamura, T., Ohan, J., Lesèche, G., Tedgui, A., Maclouf, J., & Murphy, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3985 · Cited by 172
Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment
Brennan, M., & Hazen, S. L. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200308000-00003 · Cited by 166
Miller, B. D., Alderman, E. L., Haskell, W. L., Fair, J. M., & Krauss, R. M. (1996) · Circulation · doi:10.1161/01.cir.94.9.2146 · Cited by 162
Tsimikas, S., Palinski, W., & Witztum, J. L. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.1.95 · Cited by 155
Self-citationMeasuring Circulating Oxidized Low-Density Lipoprotein to Evaluate Coronary Risk
Tsimikas, S., & Witztum, J. L. (2001) · Circulation · doi:10.1161/01.cir.103.15.1930 · Cited by 155
Self-citationHolvoet, P., Harris, T. B., Tracy, R. P., Verhamme, P. B., Newman, A. B., Rubin, S. M., Simonsick, E. M., Colbert, L. H., & Kritchevsky, S. B. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000080379.05071.22 · Cited by 154
Yamada, Y., Ichihara, S., Fujimura, T., & Yokota, M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90216-5 · Cited by 147
Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men
Krauss, R., & Dreon, D. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.2.478s · Cited by 144
Sigurdardottir, V., Fagerberg, B., & Hulthe, J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01054.x · Cited by 144
Edelstein, C., Pfaffinger, D., Hinman, J., Miller, E. R., Lipkind, G. M., Tsimikas, S., Bergmark, C., Getz, G. S., Witztum, J. L., & Scanu, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310425200 · Cited by 137
Self-citationTsimikas, S., Palinski, W., Halpern, S. E., Yeung, D. W. C., Curtiss, L. K., & Witztum, J. L. (1999) · Journal of Nuclear Cardiology · doi:10.1016/s1071-3581(99)90064-8 · Cited by 134
Self-citationBlackie, J. A., Bloomer, J. C., Brown, M. J. B., Cheng, H., Hammond, B., Hickey, D. M. B., Ife, R. J., Leach, C. A., Lewis, V. A., Macphee, C. H., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00058-1 · Cited by 128
Malondialdehyde-Modified LDL as a Marker of Acute Coronary Syndromes
Holvoet, P. (1999) · JAMA · doi:10.1001/jama.281.18.1718 · Cited by 127
Tanaga, K., Bujo, H., Inoue, M., Mikami, K., Kotani, K., Takahashi, K., Kanno, T., & Saitō, Y. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012351.63938.84 · Cited by 124
Tsimikas, S., Shortal, B. P., Witztum, J. L., & Palinski, W. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.3.689 · Cited by 123
Self-citationShimada, K., Mokuno, H., Matsunaga, E., Miyazaki, T., Sumiyoshi, K., Miyauchi, K., & Daida, H. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.029 · Cited by 122
F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases
Praticò, D., Rokach, J., Lawson, J., & FitzGerald, G. A. (2004) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.09.012 · Cited by 120
Caterina, R. D., Cipollone, F., Filardo, F. P., Zimarino, M., Bernini, W., Lazzerini, G., Bucciarelli, T., Falco, A., Marchesani, P., Muraro, R., et al. (2002) · Circulation · doi:10.1161/01.cir.0000038500.43292.d7 · Cited by 120
Wallenfeldt, K., Fagerberg, B., Wikstrand, J., & Hulthe, J. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01402.x · Cited by 119
Blencowe, C., Hermetter, A., Kostner, G. M., & Deigner, H. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31151 · Cited by 110
Myeloperoxidase and Plaque Vulnerability
Hazen, S. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000135267.82813.52 · Cited by 110
Determinants of Arterial Nitrate-Mediated Dilatation in Children
Järvisalo, M. J., Lehtimäki, T. J., & Raitakari, O. T. (2004) · Circulation · doi:10.1161/01.cir.0000129304.98566.d8 · Cited by 110
Milazzo, D., Biasucci, L. M., Luciani, N., Martinelli, L., Canosa, C., Schiavello, R., Maseri, A., & Possati, G. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00333-1 · Cited by 106
Homocysteine and Lipoprotein(a) Interact to Increase CAD Risk in Young Men and Women
Foody, J. M., MILBERG, J. A., Robinson, K., Pearce, G. L., Jacobsen, D. W., & Sprecher, D. L. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.2.493 · Cited by 103
Genetic architecture and evolution of the lipoprotein(a) trait
Utermann, G. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00007 · Cited by 92
Penny, W. F., Ben‐Yehuda, O., Kuroe, K., Long, J., Bond, A., Bhargava, V., Peterson, J. F., McDaniel, M. B., Juliano, J., Witztum, J. L., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01180-3 · Cited by 91
The effect of statin therapy on lipoprotein associated phospholipase A2 levels
Albert, M. A., Glynn, R. J., Wolfert, R. L., & Ridker, P. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.05.006 · Cited by 91
Self-citationLiu, M., Ylitalo, K., Salonen, R., Salonen, J. T., & Taskinen, M. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000135982.60383.48 · Cited by 90
Retterstøl, L., Eikvar, L., Bohn, M., Bakken, A., Erikssen, J., & Berg, K. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00595-0 · Cited by 89
Macphee, C. H. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00024-8 · Cited by 86
Torzewski, M., Shaw, P. X., Han, K.-R., Shortal, B. P., Lackner, K. J., Witztum, J. L., Palinski, W., & Tsimikas, S. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000149378.98458.fe · Cited by 79
Self-citationC-reactive protein and coronary events following percutaneous coronary angioplasty
de Winter, R. J., Koch, K. T., van Straalen, J. P., Heyde, G., Bax, M., Schotborgh, C. E., Mulder, K., Sanders, G. T., Fischer, J., Tijssen, J. G. P., et al. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00238-9 · Cited by 58
Matsumoto, T., Takashima, H., Ohira, N., Tarutani, Y., Yasuda, Y., Yamane, T., Matsuo, S., & Horie, M. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.064 · Cited by 42
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Asselbergs, F. W., Tervaert, J.-W. C., & Tio, R. A. (2004) · New England Journal of Medicine · doi:10.1056/nejm200401293500519 · Cited by 41
Molecular basis of cardiovascular disease: a companion to Braunwald’s heart disease
Kent, K. C. (1999) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(99)70096-0 · Cited by 38
Complex segregation analysis of LDL peak particle diameter
Austin, M. A., Jarvik, G. P., Hokanson, J. E., & Edwards, K. L. (1993) · Genetic Epidemiology · doi:10.1002/gepi.1370100645 · Cited by 34
Molecular Basis of Cardiovascular Disease: A companion to Braunwald's Heart Disease
Chien, K. R. (1999) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007723919838 · Cited by 26
Tsimikas, S., & Witztum, J. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02599-8 · Cited by 20
Self-citation
Cited by
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Aboyans, V., Criqui, M. H., Abraham, P., Allison, M. A., Creager, M. A., Diehm, C., Fowkes, F. G. R., Hiatt, W. R., Jönsson, B., Lacroix, P., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318276fbcb · Cited by 1,703
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Metadata
- Authors
- Tsimikas, S., Willerson, J. T., & Ridker, P. M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 47
- Issue
- 8
- Pages
- C19-C31
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2079307913
- Cited by
- 335
- References
- 132
- FWCI
- 39.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.